Funder
National Heart, Lung, and Blood Institute
Reference63 articles.
1. Economic costs of hemophilia and the impact of prophylactic treatment on patient management;Chen;Am. J. Manag. Care,2016
2. Hemophilia therapy: the future has begun;Mannucci;Haematologica,2020
3. BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A;Konkle;N. Engl. J. Med.,2020
4. Model of Short- and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia A;Zhou;J. Manag. Care Spec. Pharm.,2020
5. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A;George;N. Engl. J. Med.,2021